In CML, a clonal hematopoietic stem cell disorder, the acquisition of TKI resistance can have multiple roots where both P-gP and BCRP have a crucial role in limiting TKI intracellular concentration [37]. This evidence concerns the gene ABCG2 and chronic myelogenous leukemia, BCR-ABL1 positive.